News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
721,175 Results
Type
Article (47310)
Company Profile (346)
Press Release (673519)
Multimedia
Podcasts (79)
Webinars (12)
Section
Business (208775)
Career Advice (2039)
Deals (36043)
Drug Delivery (110)
Drug Development (84233)
Employer Resources (175)
FDA (16707)
Job Trends (15177)
News (353982)
Policy (33430)
Tag
2024 BioCapital Digital (7)
2024 BioForest Digital (6)
2024 BioForest Standard (1)
2024 BioMidwest Digital (10)
2024 BioMidwest Standard (1)
2024 Bio NC Digital (8)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (18)
2024 Biotech Beach Digital (11)
2024 Biotech Beach Standard (5)
2024 Genetown Digital (8)
2024 Genetown Standard (8)
2024 Lone Star Bio Digital (9)
2024 Pharm Country Digital (11)
2024 Pharm Country Standard (5)
2025 BioForest Digital (1)
2025 Lone Star Bio Digital (5)
2026 BioCapital Standard (1)
2026 BioMidwest Elite (1)
2026 Bio NC Standard (1)
2026 Biotech Bay Standard (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (2)
2026 Genetown Standard (1)
2026 Pharm Country Standard (2)
Academia (2726)
Academic (1)
Accelerated approval (6)
Adcomms (27)
Allergies (86)
Alliances (51059)
ALS (92)
Alzheimer's disease (1434)
Antibody-drug conjugate (ADC) (133)
Approvals (16681)
Artificial intelligence (258)
Autoimmune disease (25)
Automation (15)
Bankruptcy (366)
Best Places to Work (11913)
BIOSECURE Act (21)
Biosimilars (109)
Biotechnology (252)
Bladder cancer (67)
Brain cancer (30)
Breast cancer (280)
Cancer (2206)
Cardiovascular disease (183)
Career advice (1701)
Career pathing (29)
CAR-T (164)
Cell therapy (458)
Cervical cancer (20)
Clinical research (68174)
Collaboration (855)
Compensation (525)
Complete response letters (28)
COVID-19 (2690)
CRISPR (44)
C-suite (237)
Cystic fibrosis (106)
Data (2087)
Decentralized trials (2)
Denatured (22)
Depression (46)
Diabetes (270)
Diagnostics (6526)
Digital health (19)
Diversity (8)
Diversity, equity & inclusion (45)
Drug discovery (124)
Drug pricing (105)
Drug shortages (28)
Duchenne muscular dystrophy (98)
Earnings (87492)
Editorial (40)
Employer branding (21)
Employer resources (149)
Events (115513)
Executive appointments (713)
FDA (17916)
Featured Employer (52)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (4)
Frontotemporal dementia (8)
Funding (753)
Gene editing (112)
Generative AI (21)
Gene therapy (335)
GLP-1 (768)
Government (4538)
Grass and pollen (5)
Guidances (51)
Healthcare (19387)
Huntington's disease (24)
IgA nephropathy (24)
Immunology and inflammation (125)
Indications (27)
Infectious disease (2833)
Inflammatory bowel disease (141)
Inflation Reduction Act (8)
Influenza (50)
Intellectual property (93)
Interviews (317)
IPO (16782)
IRA (42)
Job creations (3708)
Job search strategy (1446)
Kidney cancer (10)
Labor market (36)
Layoffs (495)
Leadership (17)
Legal (8054)
Liver cancer (77)
Lung cancer (321)
Lymphoma (144)
Machine learning (5)
Management (58)
Manufacturing (301)
MASH (68)
Medical device (13599)
Medtech (13604)
Mergers & acquisitions (19785)
Metabolic disorders (710)
Multiple sclerosis (76)
NASH (18)
Neurodegenerative disease (101)
Neuropsychiatric disorders (30)
Neuroscience (1976)
NextGen: Class of 2025 (6752)
Non-profit (4618)
Northern California (2567)
Now hiring (38)
Obesity (383)
Opinion (224)
Ovarian cancer (75)
Pain (88)
Pancreatic cancer (82)
Parkinson's disease (154)
Partnered (21)
Patents (230)
Patient recruitment (102)
Peanut (48)
People (58554)
Pharmaceutical (76)
Pharmacy benefit managers (18)
Phase I (21285)
Phase II (29946)
Phase III (22390)
Pipeline (1149)
Policy (140)
Postmarket research (2739)
Preclinical (9076)
Press Release (69)
Prostate cancer (103)
Psychedelics (38)
Radiopharmaceuticals (262)
Rare diseases (413)
Real estate (6044)
Recruiting (67)
Regulatory (22937)
Reports (46)
Research institute (2488)
Resumes & cover letters (355)
Rett syndrome (4)
RNA editing (4)
RSV (43)
Schizophrenia (71)
Series A (132)
Series B (85)
Service/supplier (13)
Sickle cell disease (57)
Southern California (2211)
Special edition (17)
Spinal muscular atrophy (162)
Sponsored (29)
Startups (3731)
State (2)
Stomach cancer (16)
Supply chain (65)
Tariffs (25)
The Weekly (55)
United States (22638)
Vaccines (707)
Venture capitalists (38)
Weight loss (263)
Women's health (36)
Worklife (16)
Date
Last 7 days (488)
Last 30 days (2283)
Last 365 days (33967)
2025 (9565)
2024 (36415)
2023 (41177)
2022 (52467)
2021 (57012)
2020 (55286)
2019 (47816)
2018 (36113)
2017 (33254)
2016 (32746)
2015 (38711)
2014 (32428)
2013 (27610)
2012 (29730)
2011 (30388)
2010 (28572)
Location
Africa (768)
Alabama (52)
Alaska (7)
Arizona (235)
Arkansas (13)
Asia (39526)
Australia (6588)
California (5903)
Canada (1956)
China (515)
Colorado (260)
Connecticut (275)
Delaware (136)
Europe (87243)
Florida (881)
Georgia (211)
Idaho (58)
Illinois (530)
India (26)
Indiana (306)
Iowa (9)
Japan (153)
Kansas (105)
Kentucky (25)
Louisiana (9)
Maine (62)
Maryland (876)
Massachusetts (4513)
Michigan (215)
Minnesota (382)
Mississippi (2)
Missouri (85)
Montana (28)
Nebraska (25)
Nevada (60)
New Hampshire (67)
New Jersey (1690)
New Mexico (30)
New York (1688)
North Carolina (1011)
North Dakota (8)
Northern California (2567)
Ohio (198)
Oklahoma (15)
Oregon (34)
Pennsylvania (1331)
Puerto Rico (11)
Rhode Island (30)
South America (1142)
South Carolina (20)
South Dakota (1)
Southern California (2211)
Tennessee (101)
Texas (878)
Utah (174)
Virginia (136)
Washington D.C. (62)
Washington State (552)
West Virginia (3)
Wisconsin (52)
721,175 Results for "genetic therapy inc".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Gene therapy
Regeneron’s Gene Therapy Restores Hearing in Patients with Rare Genetic Condition
The treatment, called DB-OTO, is one of several early-stage gene therapies being developed to treat relatively straight-forward causes of genetic deafness.
February 24, 2025
·
4 min read
·
Dan Samorodnitsky
Press Releases
SpineX Inc. Announces Significant Improvement in Urinary Bladder Function in Paralyzed Individuals with SCONE™ Therapy
April 16, 2025
·
2 min read
Gene Therapy
Gene Therapies Break Through Against Genetic Hearing Loss in Children
Regeneron, Akouos and Mass Eye and Ear are testing therapies that can reverse genetic protein deficiency to restore hearing, with promising early results.
August 19, 2024
·
5 min read
·
Jill Drachenberg
Press Releases
Fifty 1 Labs, Inc. (FITY) Acquires Genetic Networks, Working to Secure Multi-Million Dollar DoD Contracts, and Positions for Rapid Expansion in Biotech Innovation
March 20, 2025
·
8 min read
Press Releases
Gene Therapy Market Is Estimated To Witness High Growth Owing To Increasing Prevalence of Genetic Disorders
December 11, 2024
·
1 min read
Press Releases
Vivos Inc. Reports Continued Progress in India Human Clinical Trial for RadioGel® Precision Radionuclide Therapy™
April 16, 2025
·
5 min read
Mergers & acquisitions
AstraZeneca Makes Potential $1B Cell Therapy Play in EsoBiotec Buy
AstraZeneca has recently been investing heavily in the cell therapy space, including two acquisitions for TeneoTwo and Gracell Biotechnologies.
March 17, 2025
·
2 min read
·
Tristan Manalac
Press Releases
Johnson & Johnson Closes Landmark Intra-Cellular Therapies, Inc. Acquisition to Solidify Neuroscience Leadership
April 2, 2025
·
10 min read
Press Releases
Shareholder Group Led by Founder Mina Sooch Nominates Majority Slate of Director Candidates to the Board of Opus Genetics, Inc.
February 7, 2025
·
10 min read
BioCapital
REGENXBIO to Participate in Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit
REGENXBIO Inc. announced it will participate in Chardan’s 8th Annual Genetic Medicines and Cell Therapy Manufacturing Summit on Monday, April 29, 2024.
April 24, 2024
·
1 min read
1 of 72,118
Next
